CorMedix Inc.

CRMD

NASDAQ

Healthcare

Biotechnology

Berkeley Heights, NJ, US64 employeescormedix.com

$7.05

+0.03(0.37%)

Mkt Cap $557M

$6.07

$16.56

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Defen Cath (85.1%), Melinta Portfolio (12.8%), Contract Revenue (2.1%).

8-K

CorMedix Inc. released an updated investor presentation (Exhibit 99.1) and reaffirmed full-year 2027 DefenCath sales guidance of $100 million to $140 million, correcting an inadvertent $100 million to $125 million statement from its March 5, 2026 earnings call. The presentation provides 2026 revenue guidance of $300–320 million and adjusted EBITDA guidance of $100–125 million.

$557M

Market Cap

$313M

Revenue

$163M

Net Income

Employees64

Fundamentals

How The Business Makes Money

Revenue by Segment

Defen Cath85.1%($302M)

Melinta Portfolio12.8%($46M)

Contract Revenue2.1%($7M)

Activity

What Changed Recently

Financial Results

Mar 4, 2026

(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject

Regulation FD

Mar 5, 2026

(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or other

Management Change+3 More

Jan 7, 2026

(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject

Peer Companies

Company	Price	Change	Market Cap	P/E
TNGXTango Therapeutics, Inc.	$21.66	+2.07%	$2.5B	-21.7
NBTXNanobiotix S.A.	$31.09	-8.76%	$1.5B	-23.8
PVLAPalvella Therapeutics, In...	$122.89	+2.08%	$1.5B	-39.3
BCAXBicara Therapeutics Inc. ...	$21.48	+4.78%	$1.2B	-8.3
SVRASavara Inc.	$5.57	-0.27%	$1.1B	-9.5
SEPNSepterna, Inc.	$25.20	+3.43%	$1.1B	-21.5
EYPTEyePoint Pharmaceuticals,...	$13.41	+3.00%	$1.1B	-4.6
ABUSArbutus Biopharma Corpora...	$4.50	-0.55%	$879M	-25.3

Analyst View

Company Profile

CIK0001410098

ISINUS21900C3088

CUSIP21900C308

Phone908 517 9500

Address300 Connell Drive, Berkeley Heights, NJ, 07922, US

SEC EDGAR